Published online March 4, 2016
•
Impressive ORR/OS in IC3 population
•
Responses maintained on time
•
Good safety profile in a fragile population
•
Results consistent over time [ESMO 2016]
•
Possible TCGA groups association
•
Who will benefit the most ?